Tag: Cancer: Lymphoma
FDA Approves Aliqopa for Follicular Lymphoma
Aliqopa, a kinase inhibitor, blocks several enzymes that promote cell growth
Immune Status Tied to Outcomes in Third-Gen CAR T-Cell Therapy
In leukemia/lymphoma, after treatment CD19-targeting chimeric antigen receptor T-cell therapy
Nephrotic Syndrome Reported With Everolimus, Voriconazole
Case report of patient with relapsed Hodgkin's lymphoma treated with everolimus for five years
Health Care Use Up for Relapse-Free Hodgkin’s Survivors
Rate of outpatient visits, inpatient bed-days up, especially for those requiring multiple chemo courses
HBV, HCV Coinfection Ups Non-Hodgkin Risk in ART-Treated HIV
Increased risk for NHL for HIV-infected patients receiving ART with chronic coinfection with HBV, HCV
Social Reintegration of Hodgkin’s Survivors Impeded by Fatigue
Significant negative association of severe fatigue and employment among male and female survivors
Remission Up With T Cell Therapy for Non-Hodgkin’s Lymphoma
Researchers identify treatment characteristics that correlate with therapeutic response, toxicity
Interim PET-CT Can Guide Treatment in Advanced Hodgkin’s
Adapted treatment guided by interim PET results linked to good overall, progression-free survival
aHSCT Should Be Standard of Care for HIV-Related Lymphoma
Outcomes after the therapy similar to those for patients who don't carry the virus
Triptorelin Doesn’t Prevent Chemo-Induced Ovarian Failure
Findings based on long-term follow-up of young patients with lymphoma
